4-oxo-4,5-dihydropyrrolo[1,2-A] quinoxaline derivatives as inhibitors of poly(ADP-ribose)polymerase(PARP)

Details for Australian Patent Application No. 2007283212 (hide)

Owner Istituto di Richerche di Biologia Molecolare P. Angeletti SpA

Inventors Schultz-Fademrecht, Carsten; Koch, Uwe; Jones, Philip; Scarpelli, Rita; Ontoria Ontoria, Jesus Maria

Agent Spruson & Ferguson

Pub. Number AU-A-2007283212

PCT Pub. Number WO2008/017883

Priority 0615809.1 09.08.06 GB

Filing date 6 August 2007

Wipo publication date 14 February 2008

International Classifications

A61K 31/4985 (2006.01) - Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems

A61P 35/00 (2006.01) Antineoplastic agents

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

Event Publications

5 February 2009 PCT application entered the National Phase

  PCT publication WO2008/017883 Priority application(s): WO2008/017883

18 August 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007283215-Novel hydrate form of O-desmethyl venlafaxine succinate

2007283210-Drive mechanism for infinitely variable transmission